Visceral Adipocyte–Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic β-Cell Insulin Secretion
Diabetes · 2024
DOI: 10.2337/db24-0177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, 2024. Verfasst von Yaqin Zhang und 19 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: MicroRNAs, Insulin-Secreting Cells, Glucose Intolerance, Extracellular Vesicles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Pancreatic β-cell dysfunction caused by obesity can be associated with alterations in the levels of miRNAs. However, the role of miRNAs in such processes remains elusive. Here, we show that pancreatic islet miR-27a-5p, which is markedly increased in obese mice and impairs insulin secretion, is mainly delivered by visceral adipocyte–derived extracellular vesicles (EVs). Depleting miR-27a-5p significantly improved insulin secretion and glucose intolerance in db/db mice. Supporting the function of EV miR-27a-5p as a key pathogenic factor, intravenous injection of miR-27a-5p–containing EVs showed their distribution in mouse pancreatic islets. Tracing the injected adeno-associated virus (AAV)-miR-27a-5p (AAV-miR-27a) or AAV-FABP4-miR-27a-5p (AAV-FABP4-miR-27a) in visceral fat resulted in upregulating miR-27a-5p in EVs and serum and elicited mouse pancreatic β-cell dysfunction. Mechanistically, miR-27a-5p directly targeted L-type Ca2+ channel subtype CaV1.2 (Cacna1c) and reduced insulin secretion in β-cells. Overexpressing mouse CaV1.2 largely abolished the insulin secretion injury induced by miR-27a-5p. These findings reveal a causative role of EV miR-27a-5p in visceral adipocyte–mediated pancreatic β-cell dysfunction in obesity-associated type 2 diabetes mellitus. Article Highlights
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Human Functional Genomics of Jiangsu Province, Nanjing Medical University, Nanjing, Jiangsu, China.
- School of Life Science and Technology, China Pharmaceutical University, Nanjing, Jiangsu, China.
- Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, Guangdong, China.
- Department of Cardiology, Xijing Hospital, Air Force Military Medical University, Xi'an, Shanxi, China.
- Department of Bioinformatics, Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Laboratory, Nanjing Pukou Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu, China.
ORCID-Profile: Yaqin Zhang, Yan Bi, Fang Chen, Dongming Su, Xiao Han
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
Zitieren
APA
Zhang, Y., Qian, B., Yang, Y., Niu, F., Lin, C., Yuan, H., Wang, J., Wu, T., Shao, Y., Shao, S., Liu, A., Wu, J., Sun, P., Chang, X., Bi, Y., Tang, W., Zhu, Y., Chen, F., Su, D., & Han, X. (2024). Visceral Adipocyte–Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic β-Cell Insulin Secretion. Diabetes. https://doi.org/10.2337/db24-0177
Vancouver
Zhang Y, Qian B, Yang Y, Niu F, Lin C, Yuan H, et al. Visceral Adipocyte–Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic β-Cell Insulin Secretion. Diabetes. 2024. doi:10.2337/db24-0177
BibTeX
@article{Zhang2024,
author = {Zhang, Yaqin and Qian, Bin and Yang, Yang and Niu, Fandi and Lin, Changsong and Yuan, Honglei and Wang, Jianan and Wu, Tijun and Shao, Yixue and Shao, Shulin and Liu, Aiming and Wu, Jingwen and Sun, Peng and Chang, Xiaoai and Bi, Yan and Tang, Wei and Zhu, Yunxia and Chen, Fang and Su, Dongming and Han, Xiao},
title = {Visceral Adipocyte–Derived Extracellular Vesicle miR-27a-5p Elicits Glucose Intolerance by Inhibiting Pancreatic β-Cell Insulin Secretion},
journal = {Diabetes},
year = {2024},
doi = {10.2337/db24-0177}
}
EUVIMED